EUVIMEDEUVIMED entdecken
Crossref

Effects of B Cell Depletion by CD19‐Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis

Jérôme Avouac iD, Anne Cauvet, Cindy Orvain, Morgane Boulch, Françoise Tilotta, Ly Tu, Raphaël Thuillet, Mina Ottaviani, Christophe Guignabert, Philippe Bousso, Yannick Allanore

Arthritis & Rheumatology · 2024-02 · 76 (2) · 268-278

DOI: 10.1002/art.42677 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 27.11.2023. Verfasst von Jérôme Avouac und 10 weiteren Autor:innen. Beteiligte Einrichtung: INSERM U1016 and UMR8104, Institut Cochin and Université Paris Cité and Hôpital Cochin, AP-HP, Centre - Université Paris Cité, Paris, France. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Scleroderma, Systemic. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Institut National de la Santé et de la Recherche Médicale, Société Française de Rhumatologie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Our goal was to study the tolerance and efficacy of two B cell depletion strategies, including one with CD19‐targeted chimeric antigen receptor (CAR) T cells, in a preclinical model mimicking the severe lung damages observed in systemic sclerosis.

Methods

B cell depletion strategies were evaluated in the Fra‐2 transgenic (Tg) mouse model. We considered a first group of 16 untreated mice, a second group of 15 mice receiving a single dose of anti‐CD20 monoclonal antibody (mAb), and a third group of 8 mice receiving CD19‐targeted CAR‐T cells in combination with anti‐CD20 monoclonal antibody. After six weeks of clinical evaluation, different validated markers of inflammation, lung fibrosis, and pulmonary vascular remodeling were assessed.

Results

CD19‐targeted CAR‐T cells infusion in combination with anti‐CD20 mAb resulted in a deeper B cell depletion than anti‐CD20 mAb alone in the peripheral blood and lesional lungs of Fra‐2 Tg mice. CAR‐T cell infusion worsened the clinical score and increased mortality in Fra‐2 Tg mice. In line with the above findings, CAR‐T cell infusion significantly increased lung collagen content, the histological fibrosis score, and right ventricular systolic pressure. CAR‐T cells accumulated in lesional lungs and promoted T activation and inflammatory cytokine production. Treatment with anti‐CD20 mAb in monotherapy had no impact on lung inflammation–driven fibrosis and pulmonary hypertension.

Conclusion

B cell therapies failed to show efficacy in the Fra2 Tg mice. The exacerbated Fra‐2 lung inflammatory burden stimulated accumulation and expansion of activated CD19‐targeted CAR‐T cells, secondarily inducing T cell activation and systemic inflammation, finally leading to disease worsening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenScleroderma, SystemicMiceAnimalsT-LymphocytesDisease Models, AnimalAntibodies, MonoclonalAntigens, CD19Mice, TransgenicFibrosis

Substanzen

Receptors, Chimeric AntigenAntibodies, MonoclonalAntigens, CD19

Autor:innen und Institutionen

  • INSERM U1016 and UMR8104, Institut Cochin and Université Paris Cité and Hôpital Cochin, AP-HP, Centre - Université Paris Cité, Paris, France.
  • INSERM U1016 and UMR8104, Institut Cochin, Paris, France.
  • Institut Pasteur, INSERM U1223, Université Paris Cité, Paris, France.
  • URP 2496 Pathologies, Imagerie et Biothérapies Orofaciales, UFR Odontologie, and Plateforme Imagerie du Vivant, Université Paris Cité, Montrouge, France.
  • INSERM UMR_S 999, Le Plessis-Robinson, and Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

ORCID-Profile: Jérôme Avouac

Förderung

  • Institut National de la Santé et de la Recherche Médicale
  • Société Française de Rhumatologie

Zitieren

APA

Avouac, J., Cauvet, A., Orvain, C., Boulch, M., Tilotta, F., Tu, L., Thuillet, R., Ottaviani, M., Guignabert, C., Bousso, P., & Allanore, Y. (2024). Effects of B Cell Depletion by CD19‐Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis. Arthritis & Rheumatology, 76(2), 268-278. https://doi.org/10.1002/art.42677

Vancouver

Avouac J, Cauvet A, Orvain C, Boulch M, Tilotta F, Tu L, et al. Effects of B Cell Depletion by CD19‐Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis. Arthritis & Rheumatology. 2024;76(2):268-278. doi:10.1002/art.42677

BibTeX
@article{Avouac2024,
  author = {Avouac, Jérôme and Cauvet, Anne and Orvain, Cindy and Boulch, Morgane and Tilotta, Françoise and Tu, Ly and Thuillet, Raphaël and Ottaviani, Mina and Guignabert, Christophe and Bousso, Philippe and Allanore, Yannick},
  title = {Effects of B Cell Depletion by CD19‐Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis},
  journal = {Arthritis & Rheumatology},
  year = {2024},
  volume = {76},
  number = {2},
  pages = {268--278},
  doi = {10.1002/art.42677}
}
Kostenlos starten →